Bristol-Myers Squibb Company (BMY)
Operating profit margin
Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating income (ttm) | US$ in thousands | -12,354,000 | -11,456,000 | -11,502,000 | -11,251,000 | -9,504,000 | -10,337,000 | -10,597,000 | -9,851,000 | -10,280,000 | -12,331,000 | -12,539,000 | -14,016,000 | -15,487,000 | -1,800,000 | -2,410,000 | -3,043,000 | -3,317,000 | -6,022,000 | 1,007,000 | 4,789,000 |
Revenue (ttm) | US$ in thousands | 48,300,000 | 47,435,000 | 46,509,000 | 45,534,000 | 45,006,000 | 44,935,000 | 45,187,000 | 45,848,000 | 46,159,000 | 46,738,000 | 47,144,000 | 46,960,000 | 46,385,000 | 45,468,000 | 44,384,000 | 42,810,000 | 42,518,000 | 39,395,000 | 34,862,000 | 31,006,000 |
Operating profit margin | -25.58% | -24.15% | -24.73% | -24.71% | -21.12% | -23.00% | -23.45% | -21.49% | -22.27% | -26.38% | -26.60% | -29.85% | -33.39% | -3.96% | -5.43% | -7.11% | -7.80% | -15.29% | 2.89% | 15.45% |
December 31, 2024 calculation
Operating profit margin = Operating income (ttm) ÷ Revenue (ttm)
= $-12,354,000K ÷ $48,300,000K
= -25.58%
The operating profit margin of Bristol-Myers Squibb Company has shown a consistent decline over the past few years, indicating a downward trend in the company's profitability from March 31, 2020, to December 31, 2024. The operating profit margin started at 15.45% in March 2020 but steadily decreased, turning negative by September 2020 and stayed negative throughout the following years.
The decline in operating profit margin can indicate challenges such as decreasing sales, increasing operating expenses, or both. A negative operating profit margin suggests that the company's operating expenses exceed its gross profit, leading to operating losses.
It is crucial for Bristol-Myers Squibb Company to closely monitor and address the factors contributing to this declining trend in operating profit margin to sustain its financial health and long-term success. Further analysis of the company's operational efficiency, cost management strategies, revenue streams, and market competition may be necessary to identify opportunities for improvement.
Peer comparison
Dec 31, 2024
See also:
Bristol-Myers Squibb Company Operating Profit Margin (Quarterly Data)